Diabetic wound healing is occasionally impaired and associated with chronic
foot ulceration and lower extremity amputation (LEA). Topically applied pl
atelet-derived growth factor (rhPDGF-BB) increases healing in less than 50
percent of these cases suggesting that other factors are involved. Ln a pre
liminary, retrospective study of diabetic ulcer patients receiving rhPDGF-B
B (becaplermin*), we show that urinary concentrations of the nitric oxide (
NO) metabolite nitrate are significantly (p<0.05) reduced in patients with
poor or absent ulcer healing as compared to patients with healed ulcers or
non-diabetic controls. This suggests that significantly decreased endogenou
s NO production predicts diabetic wound outcomes in patients treated with b
ecaplermin. These preliminary findings also appear to support further inves
tigations of the clinical use of urinary nitrate levels as a tool to guide
therapy during treatment of diabetic ulcers.